Skip to main content

Céline Moret

Scientific collaborator, biomedical ethics group, iEH2 - Institut Éthique Histoire Humanités, Université de Genève 1

Studies informed consent in high-throughput sequencing and scientific validity of direct-to-consumer genetic tests. 1

Key works

  1. Work Céline Moret et al.. 2017. “ Defining categories of actionability for secondary findings in next-generation sequencing (opens in a new tab) ” . 3

    The article sorts unexpected genomic findings by the kinds of action they allow, giving clinicians a more precise basis for deciding which results to discuss with patients.

Across Poet Doctor

Programs on interdisciplinary health humanities

Positions and training

Position Organization
Scientific collaborator, biomedical ethics group iEH2 - Institut Éthique Histoire Humanités 1

Notes

  1. Céline Moret, Université de Genève staff page (opens in a new tab) .
  2. iEH2 - Institut Éthique Histoire Humanités, official page (opens in a new tab) .
  3. “Defining categories of actionability for secondary findings in next-generation sequencing.” DOI record (opens in a new tab) .
  4. “Conversations with kidney vendors in Pakistan: an ethnographic study.” DOI record (opens in a new tab) .
  5. “Historia de la terapéutica en México. Recursos, tratamientos y procedimientos.” libros.facmed.unam.mx (opens in a new tab) .
  6. “Rethinking Conscientious Objection in Health Care.” academic.oup.com (opens in a new tab) .